Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new treatment for bone and cartilage reconstruction and reinforcement.
Promethera® Biosciences, a spin-off company of the Université catholique de Louvain, and Sopartec, the technology transfer office of the Université catholique de Louvain, presents a new hepatocyte-like cell in vitro model.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new urinary biomarker that enables an early and sensitive detection of renal dysfunction.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new tool for the differential diagnosis of rheumatic conditions.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for quantification of biomarkers on histopathological slides
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new indication for BOTOX in the treatment of cancer.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new therapeutic strategy for cardiovascular diseases.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a unique patented technology to assist upper limb’s patient in stroke rehabilitation process